Navigation Links
Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
Date:5/23/2011

equired
  • Increase in the number of patients able to avoid opioids entirely

    • For more information or to view the full posters, please visit the scientific presentations page located in the investors and media section on the Pacira website at www.pacira.com.

    About Pacira

    Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL, the company's most advanced investigational product candidate, had been accepted for filing by the U.S. Food and Drug Administration (FDA). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 28, 2011 for the review of the EXPAREL NDA. EXPAREL is a bupivacaine-based product and has completed extensive Phase 3 clinical development for postoperative analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at www.pacira.com.

    About EXPAREL™

    EXPAREL is Pacira's proprietary drug candidate consisting of bupivacaine encapsulated in DepoFoam®, both of which are currently used separately in FDA-approved products. Bupivacaine is a well-characterized anesthetic/analgesic that has an established safety profile with more than 20 years of use in the United States. Market data indicate that there is an unmet medical need for a longer-acting anesthetic/analgesic for postsurgical pain management. Several Phase 2 and Phase 3 clinical trials have been completed for EXP
    '/>"/>

    SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
    2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
    3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
    4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
    5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
    6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
    7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
    8. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
    9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    10. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
    11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2013)... , May 22, 2013 PRNewswire – ... production of a vaccine candidate for the newly ... party laboratory using the iBioLaunch™ platform. This validation ... from initial antigen sequence information to purification of ... ) The iBioLaunch platform eliminates ...
    (Date:5/22/2013)... WomanCare Global recently launched Simplant in ... training initiative attended by 90 health care providers. ... http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, a long-acting ... subdermal implant composed of two thin, flexible, silicone ... form of the hormone progestin). These are inserted ...
    (Date:5/21/2013)... BEIJING, May 21, 2013 Concord Medical Services ... CCM ), a leading specialty hospital management solution ... and diagnostic imaging centers in China and the parent ... results for the first quarter ended March 31, 2013 ... , Total net revenue, which consists of net revenues ...
    Breaking Medicine Technology:iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13
    (Date:5/22/2013)... Prussia, PA (PRWEB) May 22, 2013 The ... to announce its participation in the Greater Philadelphia Tour de ... and recreational riders who are passionate about stopping the ... than 25 million Americans. , The Tour de Cure ... located at 580 Meetinghouse Road in Ambler, 30 minutes outside ...
    (Date:5/22/2013)... York City, New York (PRWEB) May 22, 2013 ... American: Causes, Culture, Consequences, and Cost ” article published recently ... obesity is fully justified. The Centers for Disease Control ... U.S. adults aged 20 and over are overweight, 35.7% are ... facts are highlighted in this investigative article. In particular, the ...
    (Date:5/22/2013)... May 22, 2013 Synthetic Turf ... its Better Play & Recreation Contest, who collectively ... thousands of youth, people with disabilities, active troops ... rescue. The general public is encouraged to vote ... their favorite non-profit organization win the $50,000 synthetic ...
    (Date:5/22/2013)... AvePoint , the leader ... enterprise collaboration platforms, today announced a partnership with ... Chicago, Ill. The agreement will enable the two ... solutions for SharePoint deployments, enabling organizations to increase ... DocAve Software Platform and newly released ...
    (Date:5/22/2013)... 22, 2013 Many people across the ... education on how to lose weight safely and rapidly. ... and may demotivate people to continue their journey toward ... this week on Medical News Today offers ... lose weight and actually losing those initial pounds can ...
    Breaking Medicine News(10 mins):Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:Black American Obesity Examined In The Latest FinancesOnline.com Article 2Health News:Black American Obesity Examined In The Latest FinancesOnline.com Article 3Health News:Public Voting Opens for Finalists in Synthetic Turf International’s Better Play & Recreation Contest 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 3
    ... The following is a,statement in response to Patrick Swayze ... CEO of the Pancreatic Cancer,Action Network, the only national ... support, community outreach and,advocacy for a cure., "We ... with,pancreatic cancer and our thoughts go out to him ...
    ... WASHINGTON and NEWARK, N.J., March 5 Besler,& ... principal, Philip,Besler, have agreed to pay the United ... fraud against the federal Medicare program, the,Justice Department ... the North Brunswick,N.J.-headquartered company counseled hospital clients to ...
    ... MINNEAPOLIS, March 5 As two of the ... implementation of the Freedom,to Breathe Act, we are ... denounced so-called "theatrical performances" in bars as a,violation ... Freedom to Breathe Act was passed to protect ...
    ... could use,a little pampering now and then. Think your mom ... Breast Cancer Coalition,(PBCC) and Doneckers of Ephrata take care of ... in 250 words or less why your mom, as a,breast ... and you and your mom could be in for a ...
    ... says , , WEDNESDAY, March 5 (HealthDay News) -- Variations ... warfarin are important in determining the initial doses of ... is being put to medical use. Last August, the ... say that doctors should consider a genetic test when ...
    ... Spheris, a leading global,provider of clinical documentation technology and ... results for the fourth quarter,ended December 31, 2007., ... fourth quarter of,2007 after the close of market trading ... call on Thursday, March 27, 2008, at 8:00 a.m. ...
    Cached Medicine News:Health News:Patrick Swayze's Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network 2Health News:New Jersey Healthcare Consulting Firm to Pay U.S. $2.875 Million to Resolve Allegations of Medicare Fraud 2Health News:Leading Health Groups Strongly Support the Minnesota Department of Health's Efforts to Enforce Freedom to Breathe Act 2Health News:The Pennsylvania Breast Cancer Coalition Announces Last Chance to Enter 'Makeover for Mom' Contest 2Health News:Genetic Test Predicts Response to Warfarin 2Health News:Genetic Test Predicts Response to Warfarin 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: